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Plain-film coronary angiography of the cardiac explant on the operating 
table should be considered when conventional cardiac catheterization is 
desired but unavailable. We compared the effects of three contrast 
solutions on cold-preserved, isolated guinea pig hearts. Hearts were 
excised, perfused for 30 minutes, and arrested with Plegisol solution at 
7 ° C. Twenty minutes after arrest, experimental hearts were perfused 
with one of three solutions: hyperosmolar Hexabrix solution (n = 6), 
hyperosmolar Renografin-76 solution (n = 6), or diluted, isosmotic 
Omnipaque solution (n = 8). The hearts were flushed with cold Plegisol 
solution 5 minutes later. Control hearts received no contrast during 
arrest (n = 9). The hearts were reperfused after 1 hour of arrest, and 
coronary blood flow (in millimeters per minute), left ventricular devel- 
oped pressure (in millimeters of mercury), and rate of developed 
pressure (in millimeters of mercury per second) were measured. Endo- 
thelium-dependent smooth muscle relaxation to bradykinin administra- 
tion and endothelium-independent relaxation to sodium nitroprusside 
administration were also assessed. No significant difference in myocar- 
dial or endothelial function was noted between control hearts and hearts 
perfused with Omnipaque solution. Hearts perfused with Renografin 
solution or Hexabrix solution, however, were found to have significantly 
impaired endothelial and myocardial function. We conclude that an 
isosmotic ontrast solution should be used for ex vivo coronary angiog- 
raphy in cold-preserved hearts to avoid impairment of endothelial and 
myocardial function. (J Thorac Cardiovasc Surg 1996;112:306-9) 
B ecause of the inadequate supply of donors for cardiac transplantation it has become necessary 
for transplant programs to liberalize donor selection 
criteria. One area in which liberalization has oc- 
curred is the use of older heart transplant donors. 1
Concomitant with the increased age of these poten- 
tial donors is the increased risk of coronary artery 
disease. Although cardiac catheterization of donors 
before organ harvesting can identify significant cor- 
onary artery disease, we have recently encountered 
situations in which older donors have become avail- 
able in hospitals that lack cardiac catheterization ca- 
From the University of Virginia Health Sciences Center, Char- 
lottesville, Va. 
Received for publication June 22, 1995; accepted for publication 
Oct. 16, 1995. 
Address for eprints: Curtis G. Tribble, MD, University of 
Virginia, Department ofSurgery, Health Sciences Center Box 
181, Charlottesvile, VA 22908. 
Copyright © 1996 by Mosby-Year Book, Inc. 
0022-5223/96 $5.00 + 0 12/1/69950 
306 
pabilities. Occasionally, families of these donors refuse 
to allow the donor to be transported to a suitably 
equipped facility. This decision can leave the trans- 
plant team with the difficult task of deciding whether 
or not to accept he heart on the basis of inadequate 
information about the coronary circulation. 
Techniques for ex vivo coronary angiography 
have been described by Robicsek 2 and Lee and 
their associates. 3 Both groups found that the 
ionic, high-osmolar contrast solutions that they 
used demonstrated no impairment of postarrest 
myocardial function. Their studies, however, 
made no assessment of coronary endothelial func- 
tion. We have shown in a previous study that 
preservation of endothelial function is an impor- 
tant determinant of ventricular recovery after 
ischemia. 4 The goal of this study was to identify a 
contrast solution that would cause minimal im- 
pairment of ventricular and endothelial function 
in an effort to further the development of a simple 
and safe method of ex vivo visualization of donor 
coronary arteries. 
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Table I. Comparison of contrast solutions used 
Contrast Appro:dmate osrnolality, 
solution ionicity 
Dilute (37 vol%) Omnipaque 350 280 mOsm/kg • HzO, nonionic 
Full-strength Hexabrgx 600 mOsm/kg • H20, ionic 
Full-strength Renografin 1700 mOsm/kg • H20, ionic 
Material and methods 
Three different contrast solutions were chosen for 
various reasons. Renografin solution, the least expensive 
of the three, represents he most economical lternative. 
HexabrLx solution was tested and thought o be safe by 
previous investigators. 20mnipaque solution has the low- 
est osmolality at full strength and has the added advantage 
of being the only nonionic solution used. Table I illus- 
trates the approximate osmolality of the three contrast 
solutions used. 
All animals received humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
of the National Institutes of Health (NIH Publication No. 
86-23, revised 1985). 
Twenty-nine guinea pigs (300 to 350 gm) were anesthe- 
tized with intraperitoneal injections of ketamine (60 mg/ 
kg) and xylazine (6 mg/kg) and then paralyzed with 
metocurine (0.2 mg/kg) 1 minute later. Before respiratory 
arrest, the chest was opened, the trachea was intubated, 
and the lungs were mechanically ventilated. The hearts 
were rapidly excised and perfused with oxygenated Krebs- 
Henseleit bicarbonate buffer sunder constant pressure (60 
cm H20 ) at 37°C with use of a modified Langendorff 
technique. 6 Hearts were paced at 4 Hz. The right side of 
the heart was decompressed through acannula in the right 
ventricular outflow tract, and a fluid-filled latex balloon 
was placed in the left ventricle through the mitral valve 
orifice for measurements of left ventricular developed 
pressure (LVDP; in millimeters of mercury). Coronary 
blood flow (CBF; in milliliters per minute) was measured 
continuously with an in-line ultrasonic flow probe at the 
aortic root. Baseline measurements of CBF and LVDP 
were taken after 30 minutes of equilibration. All hearts 
were then arrested and preserved with cold Plegisol 
solution (7 ° C) for 1 hour. 
After 20 minutes of arrest, the experimental hearts were 
infused with one of three cold (7 ° C) contrast solutions: 
(1) Omnipaque 350 solution (n = 8) diluted to an 
isosmotic solution (37 vol%), (2) full-strength, hyperos- 
motic Hexabrix solution (n = 6), and (3) full-strength, 
hyperosmotic Renografin solution (n = 6). A total of 10 
ml of solution was infused at a rate equal to baseline CBF. 
To simulate the time required to obtain adequate radio- 
graphs, the contrast solution was flushed out with 20 ml of 
cold Plegisol solution after 5 minutes. A group of control 
hearts did not receive any contrast solutions during arrest 
(n = 9). 
At the completion of 1 hour of hypothermic arrest he 
hearts were reperfused with 37°C oxygenated Krebs- 
Henseleit bicarbonate buffer. Postresuscitation measure- 
Table II. Comparison of baseline and 
postresuscitation myocardial function 
CBF (ml/min) LVDP (mm Hg) 
Baseline Postresuscitation Baseline Postresuscitation 
Control 9 ± 0.5 9 ± 0.5 93 _+ 3 95 _+ 5 
Omnipaque 10 ± 0.7 10 ± 0.5 105 +_ 3 100 _+ 2 
solution 
Hexabrix 9 ± 0.4 7 ± 0.9 96 ± 3 51 ± 9* 
solution 
Renografin 8 +- 0.5 4 ± 0.3* 95 + 7 21 + 1" 
solution 
*p < 0.05 versus control values, otherwise not significant;  test (mean plus 
or minus standard error of mean). 
ments of CBF and LVDP were obtained after 45 minutes 
of equilibration. Vasomotor responsiveness was assessed 
by measuring changes in CBF after administration of the 
endothelium-dependent vasodilator bradykinin (1 × 1028 
mol/L) and the endothelium-independent vasodilator so- 
dium nitroprusside (1 × 10 -6 mol/L). On termination of 
the studies, all hearts were weighed after both atria were 
removed. A t test analysis was done on each set of data, 
comparing data from each contrast solution with data 
from the control group. 
In addition, to determine how well coronary arteries are 
visualized when perfused with the diluted Omnipaque 
solution, explanted hearts from recently killed large dogs 
received selective coronary artery perfusions of 10 ml of 
the diluted Omnipaque solution followed by a plain film 
roentgenogram. Radiographs were taken in the antero- 
posterior and left anterior oblique orientations at12.5 mA 
and 70 kVp. 
Results 
Table II shows the baseline and postresuscitation 
values for CBF and LVDP for all four groups of 
hearts. There were no statistically significant differ- 
ences in ventricular weight or in baseline CBF and 
LVDP values among the four groups. In addition, 
no differences in postresuscitation values existed 
between the control hearts and those hearts per- 
fused with dilute Omnipaque solution. However, 
those hearts perfused with Hexabrix solution and 
Renografin solution showed significant impairment 
of postresuscitation LVDP compared with values in 
control hearts. The Renografin solution group dis- 
played significantly decreased CBF values compared 
with those in control hearts. 
Table I l l  shows the postresuscitation vasomotor 
responses to bradykinin and sodium nitroprusside. 
Those hearts perfused with Hexabrix solution and 
Renografin solution showed significant reduction in 
endothelium-dependent a dendothelium-indepen- 
dent vasodilators compared with control hearts. 
However, hearts perfused with diluted Omnipaque 
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Table III. Postarrest peak CBF in response to 
bradykinin and sodium nitroprusside 
CBF 
CBF (ml/min) 
(ml/min) after 1 x 
after 1 × 10 6 mol/L 
10 -s  mol/L sodium 
bradykinin nitroprusside 
Control 18 _+ 2.4 14 _+ 1.3 
Omnipaque solution 15 _+ 1.9 13 _+ 0.9 
Hexabrix solution 9 _+ 1.3" 8 _+ 1.1" 
Renografin solution 4 _+ 0.3* 5 +_ 0.4* 
*p < 0.05 versus control values, otherwise not significant; t test (mean plus 
or minus standard error of mean). 
Fig. 1. Perfusion of isosmotic Omnipaque solution ade- 
quately visualizes coronary anatomy in an explanted ca- 
nine heart. 
solution maintained their responsiveness to both 
bradykinin and sodium nitroprusside. Finally, radio- 
graphs from the canine hearts perfused with Om- 
nipaque solution revealed an adequate level of 
anatomic detail (Fig. !). 
Discussion 
As is the case in other cardiac transplant pro- 
grams, many donors evaluated by the University of 
Virginia transplant program come from areas erved 
by small hospitals with limited facilities. We are 
often unable to arrange transportation to our hos- 
pital for purposes of donor evaluation. If the donor 
is young and healthy, the heart often can be har- 
vested without further evaluation. However, the 
issue of latent coronary artery disease must be 
considered when an older organ donor is being 
evaluated. 
To study the coronary anatomy at the site of harvest 
requires a technique that is quick, safe, and uses 
readily available equipment. The optimal technique 
would be one that does not cause myocardial or 
endothelial damage or dysfunction. Reports of tech- 
niques for ex vivo coronary angiography have sug- 
gested that normal postresuscitation cardiac fun tion 
can return after use of full-strength, igh-osmolality 
contrast solutions. 2'3 However, no previous studies 
have assessed preservation of endothelial function 
after administration f contrast agents. Studies done in 
our laboratory have demonstrated that preservation of
endothelial function is important to the postischemic 
function of cardiac allografts. 4 The results of this study 
suggest that an isosmotic ontrast solution is necessary 
if both myocardial nd endothelial integrity are to be 
preserved. In contrast to the findings of Lee and 
associates, 3 administration of high-osmolality ionic 
contrast solutions was associated with a significant 
reduction in ventricular function and impaired endo- 
thelial function. 
Although technically superior methods of ex vivo 
coronary angiography have been described that use 
full-strength contrast solutions, 2'3 these methods 
did not assess coronary anatomy with an isosmotic 
dilution of contrast solution. We wanted to be sure 
that coronary anatomy would still be visible with 
the dilute solution. Coronary arteries were easily 
visualized with isosmotic dilution of Omnipaque 
solution. Further work is needed, however, to ade- 
quately develop this technique for clinical applica- 
tion. 
The technique of ex vivo coronary angiography 
has other advantages besides aiding in cardiac al- 
lograft suitability. By eliminating the need for pre- 
harvest cardiac catheterization, the risks of renal 
damage from contrast loads and cholesterol embo- 
lization to other organs are also eliminated. 7' s Fur- 
thermore , substantial cost reductions could be 
achieved if this form of plain-film coronary angiog- 
raphy were to become the standard of care for 
donor hearts in place of conventional cardiac cath- 
eterization. 
In conclusion, we have demonstrated that ex vivo 
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coronary angiography is safe and effective in animal 
models  as long as isosmotic contrast solutions are 
used for the angiograms. The informat ion gained, 
the el iminat ion of risk to other donor  organs, and 
potent ia l  cost savings of this technique warrant  
further investigation. 
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